Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nadjet El-Mehidi"'
Autor:
Emma Das-Gupta, Kirsty J. Thomson, Adrian J.C. Bloor, Andrew D. Clark, Stephen Mackinnon, Irfan Kayani, Laura Clifton-Hadley, Pip Patrick, Nadjet El-Mehidi, Anthony Lawrie, Amy A. Kirkwood, Nigel H. Russell, David C. Linch, Karl S. Peggs
Publikováno v:
Blood Advances, Vol 3, Iss 24, Pp 4264-4270 (2019)
Abstract: We evaluated the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in transplant-naïve patients with relapsed/refractory Hodgkin lymphoma (HL) who failed to attain metabolic complete response (mCR) to 1 to 2 lines of s
Externí odkaz:
https://doaj.org/article/fcbef3681889418ebbc0e8a61fd4114f
Autor:
Karl S. Peggs, Stephen Mackinnon, Irfan Kayani, Emma Das-Gupta, Anthony Lawrie, Nadjet El-Mehidi, Andrew Clark, David C. Linch, Amy A Kirkwood, Adrian Bloor, Kirsty Thomson, Pip Patrick, Nigel H. Russell, Laura Clifton-Hadley
Publikováno v:
Blood Advances. 3:4264-4270
We evaluated the role of allogeneic hematopoietic stem cell transplantation (allo-HSCT) in transplant-naïve patients with relapsed/refractory Hodgkin lymphoma (HL) who failed to attain metabolic complete response (mCR) to 1 to 2 lines of salvage che
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::12e8b67e5d8ae62be701f9e664c58307
https://doi.org/10.1182/bloodadvances.2019001016
https://doi.org/10.1182/bloodadvances.2019001016
Autor:
David Cunnningham, Nicholas Counsell, John Radford, William Townsend, David C. Linch, Andrew Webb, Andrew Jack, Paul Fields, Peter Johnson, Christopher Pocock, Nadjet El-Mehidi, Paul Smith
Publikováno v:
Journal of Clinical Oncology. 32:282-287
Purpose The treatment of patients with diffuse large B-cell lymphoma (DLBCL) with cardiac comorbidity is problematic, because this group may not be able to receive anthracycline-containing chemoimmunotherapy. We designed a single-arm phase II multice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30b33f59b62445714e137539cb408ecd
https://doi.org/10.1200/jco.2013.49.7586
https://doi.org/10.1200/jco.2013.49.7586
Autor:
Nivette Braganca, Siow Ming Lee, Dianne Gilson, Roderick J. Johnson, Nadjet El-Mehidi, Peter Johnson, Andrew Davies, Wendi Qian, Paul Smith
Publikováno v:
Blood. 120:4850-4850
Abstract 4850 Background Methotrexate (MTX) remains the most important drug in the treatment of PCNSL but has considerable toxicities and is dose-limited by renal function. Glucarpidase (Voraxaze®) is an enzyme, which rapidly hydrolyses MTX and is l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b54b51b98f6bf700ebd8d01d235fe9d3
https://doi.org/10.1182/blood.v120.21.4850.4850
https://doi.org/10.1182/blood.v120.21.4850.4850
Autor:
Amy A Kirkwood, Christopher Pocock, Nadjet El-Mehidi, John Radford, David C. Linch, Andrew Webb, Paul Smith, Paul Fields, David Cunningham, Peter Johnson, William Townsend
Publikováno v:
ResearcherID
Abstract 1634FN2 Introduction: The treatment of patients with DLBCL who are unsuitable for anthracycline containing chemotherapy remains a clinical challenge. Gemcitabine is a nucleoside analogue which has proven efficacy in the relapse setting in bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5d1e35c2ccacce695abfb5467c94d69b
https://doi.org/10.1182/blood.v118.21.1634.1634
https://doi.org/10.1182/blood.v118.21.1634.1634
Autor:
Fields PA; Paul A. Fields, Guys and St Thomas' and King's College Hospitals; William Townsend, Nicholas Counsell, Paul Smith, and Nadjet El-Mehidi, Cancer Research UK and University College London Cancer Trials Centre; David C. Linch, University College London Hospital; David Cunnningham, Royal Marsden Hospital, London; Andrew Webb, Royal Sussex Cancer Centre, Brighton; Christopher Pocock, Kent and Canterbury Hospital, Kent; Andrew Jack, St James Hospital, Leeds; Peter W. Johnson, Southampton General Hospital, Southampton; and John Radford, Christie Hospital, Manchester, United Kingdom., Townsend W, Webb A, Counsell N, Pocock C, Smith P, Jack A, El-Mehidi N, Johnson PW, Radford J, Linch DC, Cunnningham D
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2014 Feb 01; Vol. 32 (4), pp. 282-7. Date of Electronic Publication: 2013 Nov 12.